Literature DB >> 24154762

The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma.

Cong-Jun Wang1, Lin Tang, Dong-Wei Shen, Chao Wang, Qiong-Ying Yuan, Wei Gao, Yong-Kun Wang, Rong-Hua Xu, Hui Zhang.   

Abstract

Hepatocellular carcinoma is a primary malignancy of hepatocytes which accounts for 80 % of all primary liver cancers. DFNA5 has been identified as a tumor suppressor gene with an important role in several frequent forms of cancers, while little is known about its role in hepatocellular carcinoma. Through comparison of the DFNA5 protein expression in hepatocellular carcinoma cells (HepG2) with human fetal lung fibroblast cells (MRC5), we found that the DFNA5 protein expression in hepatocellular carcinoma cells was significantly lower than that in normal cells. The transfection of DFNA5 gene into HepG2 cells could increase DFNA5 protein expression, which subsequently led to inhibition of cell proliferation. Underlying mechanism study revealed that decreased proliferation was due to increased apoptosis and cell cycle arrest. In view of the important role of DFNA5 gene in carcinogenesis, these findings are expected to provide new understanding on development and treatment of human hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154762     DOI: 10.1007/s11033-013-2581-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.

Authors:  Yu-Jing Zhang; Hui-Chen Wu; Hulya Yazici; Ming-Whei Yu; Po-Huang Lee; Regina M Santella
Journal:  World J Hepatol       Date:  2012-05-27

2.  Fas ligand promotes tumor immune evasion of colon cancer in vivo.

Authors:  Aideen E Ryan; Fergus Shanahan; Joe O'Connell; Aileen M Houston
Journal:  Cell Cycle       Date:  2006-02-14       Impact factor: 4.534

3.  Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.

Authors:  B R Gastman; Y Atarshi; T E Reichert; T Saito; L Balkir; H Rabinowich; T L Whiteside
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

Review 4.  Epigenetic changes in solid and hematopoietic tumors.

Authors:  Minoru Toyota; Jean-Pierre J Issa
Journal:  Semin Oncol       Date:  2005-10       Impact factor: 4.929

Review 5.  Epidemiology, risk factors and surveillance of hepatocellular carcinoma.

Authors:  G Cabibbo; A Craxì
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-04       Impact factor: 3.507

6.  The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.

Authors:  Ken Op de Beeck; Guy Van Camp; Sofie Thys; Nathalie Cools; Isabelle Callebaut; Karen Vrijens; Luc Van Nassauw; Viggo F I Van Tendeloo; Jean Pierre Timmermans; Lut Van Laer
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

7.  Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.

Authors:  Tomoko Fujikane; Noriko Nishikawa; Minoru Toyota; Hiromu Suzuki; Masanori Nojima; Reo Maruyama; Masami Ashida; Mutsumi Ohe-Toyota; Masahiro Kai; Toshihiko Nishidate; Yasushi Sasaki; Tousei Ohmura; Koichi Hirata; Takashi Tokino
Journal:  Breast Cancer Res Treat       Date:  2009-10-27       Impact factor: 4.872

8.  Nonsyndromic hearing impairment is associated with a mutation in DFNA5.

Authors:  L Van Laer; E H Huizing; M Verstreken; D van Zuijlen; J G Wauters; P J Bossuyt; P Van de Heyning; W T McGuirt; R J Smith; P J Willems; P K Legan; G P Richardson; G Van Camp
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.

Authors:  Lei Zhang; Junshan Ruan; Linggeng Yan; Weidong Li; Yu Wu; Li Tao; Feng Zhang; Shizhong Zheng; Aiyun Wang; Yin Lu
Journal:  Molecules       Date:  2012-03-26       Impact factor: 4.411

Review 10.  G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer.

Authors:  N Bucher; C D Britten
Journal:  Br J Cancer       Date:  2008-01-29       Impact factor: 7.640

View more
  31 in total

1.  Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.

Authors:  Yupeng Wang; Wenqing Gao; Xuyan Shi; Jingjin Ding; Wang Liu; Huabin He; Kun Wang; Feng Shao
Journal:  Nature       Date:  2017-05-01       Impact factor: 49.962

2.  DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR.

Authors:  Jing Guo; Junhui Yu; Mingchao Mu; Zilu Chen; Zhengshui Xu; Chenye Zhao; Kui Yang; Jianbao Zheng; Xiao Qin; Wei Zhao; Xuejun Sun
Journal:  Cell Cycle       Date:  2022-08-03       Impact factor: 5.173

Review 3.  Role of gasdermin family proteins in the occurrence and progression of hepatocellular carcinoma.

Authors:  Yandong Miao; Yonggang Chen; Denghai Mi
Journal:  Heliyon       Date:  2022-10-10

4.  Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells.

Authors:  Liang Yan; Yi Liu; Xue-Feng Ma; Dan Hou; Yu-Hui Zhang; Yong Sun; Shan-Shan Shi; Tim Forouzanfar; Hai-Yan Lin; Jun Fan; Gang Wu
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

5.  DFNA5 promoter methylation a marker for breast tumorigenesis.

Authors:  Lieselot Croes; Ken Op de Beeck; Patrick Pauwels; Wim Vanden Berghe; Marc Peeters; Erik Fransen; Guy Van Camp
Journal:  Oncotarget       Date:  2017-05-09

Review 6.  'Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death.

Authors:  Shiqiao Qiu; Jing Liu; Feiyue Xing
Journal:  Cell Death Differ       Date:  2017-03-03       Impact factor: 15.828

Review 7.  Role of GSDMB in Pyroptosis and Cancer.

Authors:  Lisha Li; Yanjing Li; Yuxian Bai
Journal:  Cancer Manag Res       Date:  2020-04-30       Impact factor: 3.989

8.  Role of DFNA5 in hearing loss and cancer - a comment on Rakusic et al.

Authors:  Lieselot Croes; Ken Op de Beeck; Guy Van Camp
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

9.  The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways.

Authors:  Sofie Van Rossom; Ken Op de Beeck; Vesna Hristovska; Joris Winderickx; Guy Van Camp
Journal:  Front Cell Neurosci       Date:  2015-07-16       Impact factor: 5.505

10.  Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.

Authors:  Bo Zhou; Jia-Yuan Zhang; Xian-Shuo Liu; Hang-Zi Chen; Yuan-Li Ai; Kang Cheng; Ru-Yue Sun; Dawang Zhou; Jiahuai Han; Qiao Wu
Journal:  Cell Res       Date:  2018-10-04       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.